Other
HCV
0
Pipeline Programs↗
0
Active Trials↗
0
Companies Involved↗
HCV is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
14
clinical trials
Completed7 · 50%
Unknown status5 · 36%
Terminated1 · 7%
Withdrawn1 · 7%
Clinical Trials
Trial Activity
14 trials
Response Modifier (Arabinoxylan Rice Bran/MGN-3/Biobran) With Interferon-Alpha for HCV
Completed·—·Phase 2·NCT02690103·37 enrolled
Ombitasvir /Paritaprevir/Ritonavir Plus Ribavirin on HCV GT4
Completed·—·Phase 1/2·NCT04378608·100 enrolled
HCV RAS Testing in Public Health Programs
Unknown status·PPost Graduate Institute of Medical Education and Research, Chandigarh·N/A·NCT04242433·200 enrolled
36 vs 48 Wks Peg-Intron Plus Ribavirin for HCV Patients Without Rapid Virologic Response But Without HCV RNA at wk 8
Unknown status·—·Phase 4·NCT01683786·60 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)